Suppr超能文献

中国产产 NDM-1 和 CMY-152 的多药耐药弗劳地柠檬酸杆菌 ST139

Multidrug-resistant Citrobacter freundii ST139 co-producing NDM-1 and CMY-152 from China.

机构信息

Academy of Military Medical Sciences, Beijing, China.

Institute for Disease Control and Prevention of PLA, Beijing, China.

出版信息

Sci Rep. 2018 Jul 13;8(1):10653. doi: 10.1038/s41598-018-28879-9.

Abstract

The emergence of carbapenemase-producing Citrobacter freundii poses a significant threat to public health worldwide. Here, we reported a C. freundii strain CWH001 which was resistant to all tested antimicrobials except tetracycline. Whole genome sequencing and analysis were performed. The strain, which belonged to a new sequence type ST139, showed close relationship with other foreign C. freundii strains through phylogenetic analysis. A novel variant of the intrinsic bla gene located on the chromosome was identified and designated as bla. Coexistence of bla with qnrS1 was found on a conjugative IncN plasmid, which had a backbone appearing in various plasmids. Other class A ESBL genes (bla and bla) were also detected on two different novel plasmids. The emergence of multidrug-resistant C. freundii is of major concern, causing great challenges to the treatment of clinical infections. Great efforts need to be taken for the specific surveillance of this opportunistic pathogen.

摘要

产碳青霉烯酶弗氏柠檬酸杆菌的出现对全球公共健康构成了重大威胁。在这里,我们报道了一株对除四环素以外的所有测试抗菌药物均具有耐药性的弗氏柠檬酸杆菌菌株 CWH001。进行了全基因组测序和分析。该菌株属于一个新的序列型 ST139,通过系统发育分析显示与其他国外弗氏柠檬酸杆菌菌株密切相关。在染色体上发现了一个位于固有 bla 基因的新型变异体,并将其命名为 bla。bla 与 qnrS1 共存于一个可接合的 IncN 质粒上,该质粒的骨架出现在各种质粒中。在两个不同的新型质粒上还检测到其他 A 类 ESBL 基因(bla 和 bla)。多药耐药性弗氏柠檬酸杆菌的出现令人高度关注,对临床感染的治疗带来了巨大挑战。需要对这种机会性病原体进行具体的监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e72/6045649/0249b2cebc84/41598_2018_28879_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验